GlassScriptPhysician profile
Lonnie T Klein
NPI 1437141645
$27,274.52
in general payments reported to CMS, 2019-2025
55 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $6,351 · 2020: $1,570 · 2021: $1,150 · 2022: $3,598 · 2023: $1,351 · 2024: $1,721 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,975 · Consulting Fee: $5,258 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,975.06 |
| Consulting Fee | $5,257.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,372.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,036.80 | 2020-2024 | Axonics, Bulkamid |
| Avyxa Pharma, LLC | $3,584.56 | 2025 | |
| Neotract INC. | $3,561.19 | 2019-2020 | |
| Medtronic, INC. | $3,111.64 | 2021-2025 | Nuro, Interstim, Infinity Occipitocervical Upper Thoracic System |
| Astrazeneca Pharmaceuticals LP | $1,665.97 | 2019-2025 | |
| Medtronic USA, INC. | $1,629.87 | 2019-2020 | |
| Verathon INC. | $1,500.00 | 2025 | Npd Clinical Study |
| Teleflex LLC | $1,356.55 | 2021-2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $1,226.07 | 2019-2024 | Aquabeam System |
| Boston Scientific Corporation | $574.56 | 2019-2025 | Spaceoar System, Axonics, General - Bph |
| Abbvie INC. | $560.69 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $503.26 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $338.95 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $275.73 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $248.61 | 2019-2024 | Xiaflex, Aveed, Edex |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $230.39 | 2019-2021 | |
| Coloplast Corp | $170.68 | 2020-2025 | Speedicath |
| Novartis Pharmaceuticals Corporation | $162.45 | 2024-2025 | |
| Janssen Biotech, INC. | $155.24 | 2019-2025 | Erleada |
| Palette Life Sciences, INC. | $153.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.29 | 2019-2025 | |
| Telix Pharmaceuticals | $151.12 | 2023-2025 | Illuccix |
| Penumbra, INC. | $149.97 | 2024 | Ruby Coil |
| Ferring Pharmaceuticals INC. | $149.04 | 2019-2025 | Adstiladrin |
| Urogen Pharma, INC. | $143.65 | 2022-2025 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $120.58 | 2020-2022 | |
| Allergan, INC. | $114.66 | 2019-2022 | |
| Tolmar, INC. | $114.55 | 2023-2024 | |
| Endo USA, INC. | $107.72 | 2024-2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $95.06 | 2022-2025 | Keytruda, Lynparza |
| Antares Pharma, INC. | $79.95 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Rochester Medical Corporation | $76.95 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $76.46 | 2019-2023 | Bard Urinary Drainage Bag |
| Verity Pharmaceuticals INC. | $73.44 | 2023-2025 | Trelstar, Tlando |
| Accord Healthcare, INC. | $71.49 | 2023-2025 | |
| Bioprotect Medical, INC. | $59.33 | 2025 | Bioprotect Balloon Implant System |
| 180 Medical, INC. | $58.79 | 2020 | |
| Myovant Sciences INC. | $57.00 | 2021-2022 | |
| Amgen INC. | $50.12 | 2019 | |
| Acerus Pharmaceuticals Corporation | $39.70 | 2020-2021 | |
| Calyxo, INC. | $39.29 | 2025 | Cvac Aspiration System |
| Tempus Ai, INC | $37.67 | 2024-2025 | Xt Cdx |
| Bluewind Medical | $27.33 | 2025 | |
| Foundation Medicine, INC. | $22.79 | 2023 | |
| Laborie Medical Technologies Corp. | $21.27 | 2025 | |
| Urovant Sciences INC | $19.90 | 2022 | |
| Progenics Pharmaceuticals, INC. | $18.65 | 2025 | |
| Sun Pharmaceutical Industries INC. | $18.31 | 2019 | |
| Mimedx Group, INC. | $17.95 | 2024 | |
| Angiodynamics, INC. | $17.74 | 2024 | Nanoknife |
| Srs Medical Systems, INC. | $16.23 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.88 | 2020 | |
| Dentsply Ih INC. | $13.54 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$532.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lonnie Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.